URMC / Labs / Beck Lab / Publications

Recent Publications

1. Kenney HM
2. Yoshida T
3. Berdyshev E
4. Calatroni A
5. Gill SR
6. Simpson EL
7. Lussier S
8. Boguniewicz M
9. Hata T
10. Chiesa Fuxench ZC
11. De Benedetto A
12. Ong PY
13. Ko J
14. Davidson W
15. David G
16. Schlievert PM
17. Leung DYM
18. Beck LA
CERS1 is a Biomarker of Staphylococcus aureus Abundance and Atopic Dermatitis Severity.; The Journal of allergy and clinical immunology. 2024 Sep 27.
1. Beck LA
2. Muraro A
3. Boguniewicz M
4. Chen Z
5. Zahn J
6. Marco AR
Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis.; The Journal of allergy and clinical immunology. 2024 Aug 21.
1. Beck LA
2. Bissonnette R
3. Deleuran M
4. Nakahara T
5. Galus R
6. Coleman A
7. Gherardi G
8. Xiao J
9. Dingman R
10. Xu C
11. Avetisova E
12. Dubost-Brama A
13. Shabbir A
Dupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension Study.; JAMA dermatology. 2024 Jul 10.
1. Peterson LF
2. Beck LA
3. Brewer MG
The mycobiome affects viral susceptibility of skin epithelium.; Journal de mycologie medicale; Vol 34(3), pp. 101499. 2024 Jul 09.
1. Mark Kenney H
2. Battaglia J
3. Herman K
4. Beck LA
Atopic Dermatitis and IgE-Mediated Food Allergy: Common Biologic Targets for Therapy and Prevention.; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2024 Jun 20.
1. Chu AWL
2. Rayner DG
3. Chu X
4. Chen L
5. Dong AYH
6. Waserman S
7. Baker DR
8. Sheikh J
9. Moellman J
10. Lang DM
11. Ben-Shoshan M
12. Mathur SK
13. Beck LA
14. Khan DA
15. Oliver ET
16. Asiniwasis RN
17. Chan J
18. Cole EF
19. Trayes KP
20. Frazier WT
21. Runyon L
22. Wheeler KE
23. Eftekhari S
24. Gardner DD
25. Winders T
26. Bernstein JA
27. Saini SS
28. Chu DK
Topical corticosteroids for hives and itch (urticaria): systematic review and Bayesian meta-analysis of randomized trials.; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2024 Jun 18.
1. Rayner DG
2. Liu M
3. Chu AWL
4. Chu X
5. Guyatt GH
6. Oykhman P
7. Cao DJ
8. Moellman J
9. Ben-Shoshan M
10. Baker DR
11. Waserman S
12. Lang D
13. Sheikh J
14. Mathur SK
15. Beck LA
16. Khan DA
17. Oliver ET
18. Asiniwasis RN
19. Cole EF
20. Wheeler KE
21. Runyon L
22. Chan J
23. Trayes KP
24. Eftekhari S
25. Gardner DD
26. Winders T
27. Saini SS
28. Bernstein J
29. Chu DK
Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: a systematic review and meta-analysis of randomized clinical trials.; The Journal of allergy and clinical immunology. 2024 Jun 07.
1. Chu X
2. Wang J
3. Ologundudu L
4. Brignardello-Petersen R
5. Guyatt GH
6. Oykhman P
7. Bernstein JA
8. Saini SS
9. Beck LA
10. Waserman S
11. Moellman J
12. Khan DA
13. Ben-Shoshan M
14. Baker DR
15. Oliver ET
16. Sheikh J
17. Lang D
18. Mathur SK
19. Winders T
20. Eftekhari S
21. Gardner DD
22. Runyon L
23. Asiniwasis RN
24. Cole EF
25. Chan J
26. Wheeler KE
27. Trayes KP
28. Tran P
29. Chu DK
Efficacy and Safety of Systemic Corticosteroids for Urticaria: A systematic review and meta-analysis of randomized clinical trials.; The journal of allergy and clinical immunology. In practice. 2024 Apr 18.
1. Ryan Wolf J
2. Chen A
3. Wieser J
4. Johnson B
5. Baughman L
6. Lee G
7. Pope E
8. Franco A
9. Love T
10. Beck LA
Improved patient- and caregiver-reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2024 Feb 15.
1. Stolarczyk A
2. Perez-Nazario N
3. Knowlden SA
4. Chinchilli E
5. Grier A
6. Paller A
7. Gill SR
8. De Benedetto A
9. Yoshida T
10. Beck LA
Bleach baths enhance skin barrier, reduce itch but do not normalize skin dysbiosis in atopic dermatitis.; Archives of dermatological research. 2023 Sep 27.
1. Moran MC
2. Brewer MG
3. Schlievert PM
4. Beck LA
S. aureus virulence factors decrease epithelial barrier function and increase susceptibility to viral infection.; Microbiology spectrum. 2023 Sep 22.
1. Moran MC
2. Klose A
3. Yoshida T
4. De Benedetto A
5. Schneider LC
6. Ong PY
7. Simpson EL
8. Leung DYM
9. Miller BL
10. Seplaki CL
11. Beck LA
History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis.; Dermatology and therapy. 2023 Aug 24.
1. Guttman-Yassky E
2. Silverberg JI
3. Thaçi D
4. Papp KA
5. Ständer S
6. Beck LA
7. Kim BS
8. Hu X
9. Liu J
10. Calimlim BM
11. Vigna N
12. Crowley JT
13. Teixeira HD
14. Thyssen JP
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: results from a phase 2b, randomized, controlled trial.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2023 Aug 01.
1. Reich K
2. Silverberg JI
3. Papp KA
4. Deleuran M
5. Katoh N
6. Strober B
7. Beck LA
8. de Bruin-Weller M
9. Werfel T
10. Zhang F
11. Biswas P
12. DiBonaventura MD
13. Chan G
14. Johnson S
15. Farooqui SA
16. Kerkmann U
17. Clibborn C
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2023 Jun 19.
1. Reich K
2. Silverberg JI
3. Papp KA
4. Deleuran M
5. Katoh N
6. Strober B
7. Beck LA
8. de Bruin-Weller M
9. Werfel T
10. Zhang F
11. Biswas P
12. DiBonaventura MD
13. Chan G
14. Farooqui SA
15. Kerkmann U
16. Clibborn C
Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2023 Jun 15.
1. Simpson EL
2. Schlievert PM
3. Yoshida T
4. Lussier S
5. Boguniewicz M
6. Hata T
7. Fuxench Z
8. De Benedetto A
9. Ong PY
10. Ko J
11. Calatroni A
12. Rudman Spergel AK
13. Plaut M
14. Quataert SA
15. Kilgore SH
16. Peterson L
17. Gill AL
18. David G
19. Mosmann T
20. Gill SR
21. Leung DYM
22. Beck LA
Rapid Reduction in Staphylococcus aureus in Atopic Dermatitis Subjects Following Dupilumab Treatment.; The Journal of allergy and clinical immunology. 2023 Jun 12.
1. Guttman-Yassky E
2. Bahadori L
3. Brooks L
4. Clark KL
5. Grindebacke H
6. Ho CN
7. Katial R
8. Pham TH
9. Walton C
10. Datto CJ
Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.; Journal of the European Academy of Dermatology and Venereology : JEADV; Vol 37(10), pp. e1211-e1214. 2023 Jun 12.
1. Arnold KA
2. Peterson LF
3. Beck LA
4. Brewer MG
JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes.; International journal of molecular sciences; Vol 24(11). 2023 May 25.
1. Simpson EL
2. De Benedetto A
3. Boguniewicz M
4. Ong PY
5. Lussier S
6. Villarreal M
7. Schneider LC
8. Paller AS
9. Guttman-Yassky E
10. Hanifin JM
11. Spergel JM
12. Barnes KC
13. David G
14. Austin B
15. Leung DYM
16. Beck LA
Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity from the ADRN Registry.; The journal of allergy and clinical immunology. In practice. 2023 May 12.
1. Moran MC
2. Chinchilli E
3. Kenney HM
4. Pope EM
5. Scott G
6. Brewer MG
7. Beck LA
Stage of Keratinocyte Differentiation is a Key Determinant of Viral Susceptibility in Human Skin.; The Journal of investigative dermatology. 2023 Mar 28.
1. Zuberbier T
2. Beck LA
3. Bedbrook A
4. de Bruin-Weller M
5. Bousquet J
6. Cork M
7. Douladiris N
8. Katoh N
9. Mortz CG
10. Werfel T
11. Wojciech F
12. Wollenberg A
13. Siemens K
14. Stevanovic K
15. Worm M
Developing integrated care pathways for atopic dermatitis-Challenges and unmet needs.; Clinical and translational allergy; Vol 13(3), pp. e12236. 2023 Mar.
1. Smith HD
2. Williams B
3. Beck LA
4. De Benedetto A
Erythema Multiforme Secondary to Poison Ivy Contact Dermatitis.; Dermatitis : contact, atopic, occupational, drug. 2023 Feb 27.
1. Yang B
2. Wilkie H
3. Das M
4. Timilshina M
5. Bainter W
6. Woods B
7. Daya M
8. Boorgula MP
9. Mathias RA
10. Lai P
11. Petty CR
12. Weller E
13. Harb H
14. Leung DYM
15. Beck LA
16. Simpson EL
17. Hata TR
18. Barnes KC
19. Phipatanakul W
20. Leyva-Castillo JM
21. Geha RS
The IL-4Rα Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice.; The Journal of allergy and clinical immunology. 2023 Jan 20.
1. Bissonnette R
2. Simpson E
3. Eichenfield LF
4. Guttman-Yassky E
5. Silverberg JI
6. Beck LA
7. Mija L
8. Thyssen JP
9. Bieber T
10. Kabashima K
11. Siegfried E
12. Stingl G
13. van de Kerkhof P
14. Yosipovitch G
15. Paul C
16. Paller AS
The vIGA-AD scale for atopic dermatitis: uptake in the past five years and position of the International Eczema Council.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2023 Jan 09.
1. Schlievert PM
2. Kilgore SH
3. Beck LA
4. Yoshida T
5. Klingelhutz AJ
6. Leung DYM
Host Cationic Antimicrobial Molecules Inhibit S. aureus Exotoxin Production.; mSphere. 2023 Jan 04.
1. Moran MC
2. Pope EM
3. Brewer MG
4. Beck LA
Supply Chain Disruptions During COVID Pandemic Uncover Differences in Keratinocyte Culture Media.; JID innovations : skin science from molecules to population health. 2022 Aug 22.
1. Paller AS
2. Beck LA
Bleach baths for atopic dermatitis: Evidence of efficacy but more data are needed.; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology; Vol 128(6). 2022 Jun.
1. Beck LA
2. Deleuran M
3. Bissonnette R
4. de Bruin-Weller M
5. Galus R
6. Nakahara T
7. Seo SJ
8. Khokhar FA
9. Vakil J
10. Xiao J
11. Marco AR
12. Levit NA
13. O'Malley JT
14. Shabbir A
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.; American journal of clinical dermatology. 2022 May 03.
1. Beck LA
2. Cork MJ
3. Amagai M
4. De Benedetto A
5. Kabashima K
6. Hamilton JD
7. Rossi AB
Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.; JID innovations : skin science from molecules to population health; Vol 2(5), pp. 100131. 2022 Apr 26.
1. Brewer MG
2. Monticelli SR
3. Moran MC
4. Miller BL
5. Beck LA
6. Ward BM
Conditions That Simulate the Environment of Atopic Dermatitis Enhance Susceptibility of Human Keratinocytes to Vaccinia Virus.; Cells; Vol 11(8). 2022 Apr 14.
1. Pope EM
2. Laageide L
3. Beck LA
Management of Allergic Skin Disorders in Pregnancy.; Immunology and allergy clinics of North America; Vol 43(1), pp. 117-132. 2022 Jan 28.
1. Paller AS
2. Beck LA
3. Blauvelt A
4. Siegfried EC
5. Cork MJ
6. Wollenberg A
7. Chen Z
8. Khokhar FA
9. Vakil J
10. Zhang A
11. Bansal A
12. Cyr SL
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.; Pediatric dermatology. 2022 Jan 26.
1. Beck LA
2. Pesonen M
3. Thakar J
4. Georas SN
5. Järvinen KM
IgE Sensitization Drives the Atopic March.; American journal of respiratory and critical care medicine. 2022 Jan 08.
1. Beck LA
2. Bieber T
3. Weidinger S
4. Tauber M
5. Saeki H
6. Irvine AD
7. Eichenfield LF
8. Werfel T
9. Arlert P
10. Jiang L
11. Røpke M
12. Paller AS
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.; Journal of the American Academy of Dermatology. 2022 Jan 03.
1. Herman KE
2. Yoshida T
3. Hughson A
4. Grier A
5. Gill SR
6. Beck LA
7. Fowell DJ
IL-17-Dependent Dysregulated Cutaneous Immune Homeostasis in the Absence of the Wiskott-Aldrich Syndrome Protein.; Frontiers in immunology; Vol 13. 2022.
1. Yoshida T
2. Beck LA
3. De Benedetto A
Skin barrier defects in atopic dermatitis: From old idea to new opportunity.; Allergology international : official journal of the Japanese Society of Allergology. 2021 Dec 13.
1. Tuttle KL
2. Forman J
3. Beck LA
Novel systemic treatments in atopic dermatitis: Are there sex differences?; International journal of women's dermatology; Vol 7(5Part A). 2021 Dec.
1. Wollenberg A
2. Beck LA
3. de Bruin Weller M
4. Simpson EL
5. Imafuku S
6. Boguniewicz M
7. Zachariae R
8. Olsen CK
9. Thyssen JP
Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials.; The British journal of dermatology. 2021 Oct 12.
1. Daya M
2. Cox C
3. Acevedo N
4. Boorgula MP
5. Campbell M
6. Chavan S
7. Cho MH
8. David GL
9. Kachroo P
10. Lasky-Su J
11. Li X
12. McHugh CP
13. Qiao D
14. Rafaels N
15. Beck LA
16. Bleecker ER
17. Caraballo L
18. Cupples AL
19. Figueiredo CA
20. Gallo RL
21. Hanifin J
22. Hansel NN
23. Hata TR
24. Hersh CP
25. Knight-Madden J
26. Leung DYM
27. Guttman-Yassky E
28. Meyers DA
29. O'Connor G
30. Ober C
31. Ong PY
32. Ortega VE
33. Paller AS
34. Putcha N
35. Reed RM
36. Schneider LC
37. Silverman EK
38. Slifka MK
39. Spergel JM
40. Vasan RS
41. Viaud-Martinez KA
42. Watson H
43. Weiss ST
44. Ruczinski I
45. Beaty TH
46. Mathias RA
47. Barnes KC
Multi-ethnic genome-wide and HLA association study of total serum IgE.; The Journal of allergy and clinical immunology. 2021 Sep 15.
1. Arehart CH
2. Daya M
3. Campbell M
4. Boorgula MP
5. Rafaels N
6. Chavan S
7. David G
8. Hanifin J
9. Slifka MK
10. Gallo RL
11. Hata T
12. Schneider LC
13. Paller AS
14. Ong PY
15. Spergel JM
16. Guttman-Yassky E
17. Leung DYM
18. Beck LA
19. Gignoux CR
20. Mathias RA
21. Barnes KC
Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors.; The Journal of allergy and clinical immunology. 2021 Jun 07.
1. Moran MC
2. Pandya RP
3. Leffler KA
4. Yoshida T
5. Beck LA
6. Brewer MG
Characterization of Human Keratinocyte Cell Lines for Barrier Studies.; JID innovations; Vol 1(2). 2021 Jun.
1. Siegfried EC
2. Bieber T
3. Simpson EL
4. Paller AS
5. Beck LA
6. Boguniewicz M
7. Schneider LC
8. Khokhar FA
9. Chen Z
10. Prescilla R
11. Mina-Osorio P
12. Bansal A
Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial.; American journal of clinical dermatology. 2021 Mar 03.
1. Mahadevan N
2. Christakis Y
3. Di J
4. Bruno J
5. Zhang Y
6. Dorsey ER
7. Pigeon WR
8. Beck LA
9. Thomas K
10. Liu Y
11. Wicker M
12. Brooks C
13. Kabiri NS
14. Bhangu J
15. Northcott C
16. Patel S
Development of digital measures for nighttime scratch and sleep using wrist-worn wearable devices.; NPJ digital medicine; Vol 4(1). 2021 Mar 03.
1. Beck LA
2. Thaçi D
3. Deleuran M
4. de Bruin-Weller M
5. Chen Z
6. Khokhar FA
7. Zhang M
8. Ozturk ZE
9. Shumel B
Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study.; The Journal of dermatological treatment. 2021 Feb 08.
1. Bin L
2. Malley C
3. Taylor P
4. PreethiBoorgula M
5. Chavan S
6. Daya M
7. Mathias M
8. Shankar G
9. Rafaels N
10. Vergara C
11. Potee J
12. Campbell M
13. Hanifin JM
14. Simpson E
15. Schneider LC
16. Gallo RL
17. Hata T
18. Paller AS
19. De Benedetto A
20. Beck LA
21. Ong PY
22. Guttman-Yassky E
23. Richers B
24. Baraghoshi D
25. Ruczinski I
26. Barnes K
27. Leung DYM
28. Mathias RA
Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum.; Allergy. 2021 Feb 06.
1. Boguniewicz M
2. Beck LA
3. Sher L
4. Guttman-Yassky E
5. Thaçi D
6. Blauvelt A
7. Worm M
8. Corren J
9. Soong W
10. Lio P
11. Rossi AB
12. Lu Y
13. Chao J
14. Eckert L
15. Gadkari A
16. Hultsch T
17. Ruddy M
18. Mannent LP
19. Graham NMH
20. Pirozzi G
21. Chen Z
22. Ardeleanu M
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis.; The journal of allergy and clinical immunology. In practice. 2021 Jan 13.
1. Bawany F
2. Northcott CA
3. Beck LA
4. Pigeon WR
Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies.; The journal of allergy and clinical immunology. In practice. 2020 Dec 12.
1. Bawany F
2. Franco AI
3. Beck LA
Dupilumab: One therapy to treat multiple atopic diseases.; JAAD case reports; Vol 6(11). 2020 Nov.
1. Beck LA
2. Silverberg JI
3. Simpson EL
4. Yosipovitch G
5. Eckert L
6. Guillemin I
7. Chen Z
8. Ardeleanu M
9. Plaum S
10. Graham N
11. Ruddy M
12. Pirozzi G
13. Gadkari A
Dupilumab Significantly Improves Sleep Outcomes in Adult Patients with Atopic Dermatitis: Results from Five Randomized Clinical Trials.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2020 Aug 12.
1. Paller AS
2. Siegfried EC
3. Thaçi D
4. Wollenberg A
5. Cork MJ
6. Arkwright PD
7. Gooderham M
8. Beck LA
9. Boguniewicz M
10. Sher L
11. Weisman J
12. O'Malley JT
13. Patel N
14. Hardin M
15. Graham NMH
16. Ruddy M
17. Sun X
18. Davis JD
19. Kamal MA
20. Khokhar FA
21. Weinreich DM
22. Yancopoulos GD
23. Beazley B
24. Bansal A
25. Shumel B
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial.; Journal of the American Academy of Dermatology. 2020 Jun 20.